A carregar...
Molecular Characterization of Head and Neck Cancer: How Close to Personalized Targeted Therapy?
Molecular targeted therapy in squamous head and neck cancer (HNSCC) continues to make strides and holds much promise. Cetuximab remains the sole FDA-approved molecular targeted therapy available for HNSCC, though there are several new biological agents targeting the epidermal growth factor receptor...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3707609/ https://ncbi.nlm.nih.gov/pubmed/22873739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11635330-000000000-00000 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|